Trade NTRA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Natera, Inc. (NTRA) is trading at US$328.18, up 0.16% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$47.86B. Over the past 52 weeks, NTRA has traded between US$157.43 and US$343.18. On Syfe you can trade NTRA with $0 commission and add it to your watchlist.
| Previous close | US$327.67 |
|---|---|
| Market cap | US$47.86B |
| 52-week range | US$157.43 – US$343.18 |
| Volume | 968.03K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Natera, Inc.
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Year: 2015
RBC Capital Adjusts Price Target on Natera to $350 From $275, Maintains Outperform Rating
Aug 7, 12:47 PM · MT Newswires
Natera Q2 Loss Narrows, Revenue Rises; 2026 Revenue Outlook Raised
Aug 6, 8:17 PM · MT Newswires
Natera, Inc. (NTRA) stock is trading at US$328.18, +0.16% from the previous close of US$327.67.
The market cap for Natera, Inc. (NTRA) stock is approximately US$47.86B.
The 52-week high for Natera, Inc. (NTRA) stock is US$343.18.
The 52-week low for Natera, Inc. (NTRA) stock is US$157.43.
Natera, Inc. (NTRA) does not currently pay a dividend.
Stay on top of NTRA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
